Goldman Urology has recently adopted 'URO dot AI', an artificial intelligence (AI)-based urinary stone detection solution. The system is a software platform that automatically analyzes non-contrast computed tomography (CT) scans to determine the presence, size, and location of urinary stones, enabling faster and more precise stone identification.
Previously, urologists had to manually review CT images one by one, a time-consuming process that also carried the risk of missing small stones. 'URO dot AI' resolves this by delivering results within 5 minutes, simultaneously improving the speed and accuracy of patient consultations.
Notably, the system anatomically analyzes the entire urinary tract—including the ureter, kidney, and bladder—and can detect even difficult-to-find stones smaller than 4mm. It also displays the real-time location and size of stones, directly supporting the planning of treatment strategies.
From the patient's perspective, the diagnostic benefits are significant. The rapid analysis enables faster pain management in emergency situations. Accurate size and location data reduces unnecessary repeat examinations and unnecessary surgical attempts. Furthermore, the ability to detect small stones that conventional X-ray or ultrasound examinations might miss enables earlier diagnosis and treatment.
Clinical trials of 'URO dot AI' have demonstrated exceptional performance: in the primary efficacy assessment, it recorded a sensitivity of 97.89% and specificity of 94.12%. In the secondary assessment, it achieved sensitivity of 98.82% and specificity of 96.67%. Most impressively, it achieved 100% accuracy in detecting stones with a diameter of 5mm or more, establishing a high level of clinical reliability.
Most significantly, 'URO dot AI' has been officially designated as an innovative medical technology by the Korean Ministry of Health and Welfare after passing rigorous evaluations for both safety and efficacy.
A Goldman Urology representative stated, "URO dot AI is a technology that will bring new diagnostic achievements to the diagnostic process. We will continue to strive to provide our patients with even more precise and systematic medical care."